Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ramsha Iqbal"'
Autor:
Jaseela Majeed, Sapna Yadav, Rekha Garg Garg, Danish Kamal, Ramsha Iqbal, Palka Mittal, Abhishek Dadhich, Puneeta Ajmera
Publikováno v:
Journal of the Dow University of Health Sciences, Vol 4, Iss 09 (2023)
Objective: This meta-analysis is aimed to quantify the findings of different meta-analyses performed on the association of hepatic and gastrointestinal complications and COVID-19 severity. Methods: Four databases i.e., PubMed, Google Scholar, Cochran
Externí odkaz:
https://doaj.org/article/42aa07171874477a93af0e67fbb5d4eb
Autor:
Ramsha Iqbal, Md Sayeed Akhtar, Md Quamrul Hassan, Zeeba Jairajpuri, Mohd. Akhtar, Abul Kalam Najmi
Publikováno v:
Clinical and Experimental Hypertension, Vol 41, Iss 5, Pp 434-443 (2019)
Pitavastatin inhibits 3 hydroxy 3 methyl glutaryl coenzyme A (HMGCoA) reductase enzyme, preventing cholesterol synthesis along with elevating high density apolipoprotein A1 (Apo-A1). The present study was designed to evaluate cardioprotective potenti
Externí odkaz:
https://doaj.org/article/e9b8835fca954125a6a342658a79889e
Autor:
Ramsha Iqbal, Lemonitsa H. Mammatas, Tuba Aras, Wouter V. Vogel, Tim van de Brug, Daniela E. Oprea-Lager, Henk M. W. Verheul, Otto S. Hoekstra, Ronald Boellaard, Catharina W. Menke-van der Houven van Oordt
Publikováno v:
Diagnostics, Vol 11, Iss 11, p 1954 (2021)
Positron emission tomography using [18F]fluorodeoxyglucose (FDG PET) potentially underperforms for staging of patients with grade 1–2 estrogen receptor positive (ER+) breast cancer. The aim of this study was to retrospectively investigate the diagn
Externí odkaz:
https://doaj.org/article/d8c988063f0c45489f71114b436b3760
Autor:
Yeukman Liu, Robert C. Schuit, Andy Beelen, Ramsha Iqbal, Catharina W Menke-van der Houven van Oordt, D.E. Oprea-Lager, Anne Marije Luik, Albert D. Windhorst, Maqsood Yaqub, Ronald Boellaard
Publikováno v:
Journal of Nuclear Medicine, 63(5), 694-699. Society of Nuclear Medicine Inc.
Iqbal, R, Yaqub, M, Oprea-Lager, D E, Liu, Y, Luik, A M, Beelen, A P, Schuit, R C, Windhorst, A D, Boellaard, R & der Houven van Oordt, C W M-V 2022, ' Biodistribution of 18F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER Degrader ', Journal of Nuclear Medicine, vol. 63, no. 5, pp. 694-699 . https://doi.org/10.2967/jnumed.121.262500, https://doi.org/10.2967/jnumed.121.262500
Iqbal, R, Yaqub, M, Oprea-Lager, D E, Liu, Y, Luik, A M, Beelen, A P, Schuit, R C, Windhorst, A D, Boellaard, R & der Houven van Oordt, C W M-V 2022, ' Biodistribution of 18F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER Degrader ', Journal of Nuclear Medicine, vol. 63, no. 5, pp. 694-699 . https://doi.org/10.2967/jnumed.121.262500, https://doi.org/10.2967/jnumed.121.262500
16α-18F-fluoro-17β-estradiol (18F-FES) is a positron emission tomography (PET) tracer characterizing the expression of the estrogen receptor (ER). As therapy can interfere with the kinetics and biodistribution of 18F-FES, the aim of this study was
Autor:
Ramsha Iqbal, Maqsood Yaqub, Huseyyin O. Bektas, Daniela E. Oprea-Lager, Elisabeth G.E. de Vries, Andor W.J.M. Glaudemans, Philippe Aftimos, Géraldine Gebhart, Andrew P. Beelen, Robert C. Schuit, Albert D. Windhorst, Ronald Boellaard, C. Willemien Menke-van der Houven van Oordt
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, 29(11), 2075-2084. American Association for Cancer Research Inc.
Iqbal, R, Yaqub, M, Bektas, H O, Oprea-Lager, D E, de Vries, E G E, Glaudemans, A W J M, Aftimos, P, Gebhart, G, Beelen, A P, Schuit, R C, Windhorst, A D, Boellaard, R & Menke-van der Houven van Oordt, C W 2023, ' 18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant ', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 29, no. 11, pp. 2075-2084 . https://doi.org/10.1158/1078-0432.CCR-22-2720
Iqbal, R, Yaqub, M, Bektas, H O, Oprea-Lager, D E, de Vries, E G E, Glaudemans, A W J M, Aftimos, P, Gebhart, G, Beelen, A P, Schuit, R C, Windhorst, A D, Boellaard, R & Menke-van der Houven van Oordt, C W 2023, ' [ 18 F]FDG and [ 18 F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ERþ Breast Cancer Undergoing Treatment with Rintodestrant ', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 29, no. 11, pp. 2075-2084 . https://doi.org/10.1158/1078-0432.CCR-22-2720
Iqbal, R, Yaqub, M, Bektas, H O, Oprea-Lager, D E, de Vries, E G E, Glaudemans, A W J M, Aftimos, P, Gebhart, G, Beelen, A P, Schuit, R C, Windhorst, A D, Boellaard, R & Menke-van der Houven van Oordt, C W 2023, ' 18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant ', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 29, no. 11, pp. 2075-2084 . https://doi.org/10.1158/1078-0432.CCR-22-2720
Iqbal, R, Yaqub, M, Bektas, H O, Oprea-Lager, D E, de Vries, E G E, Glaudemans, A W J M, Aftimos, P, Gebhart, G, Beelen, A P, Schuit, R C, Windhorst, A D, Boellaard, R & Menke-van der Houven van Oordt, C W 2023, ' [ 18 F]FDG and [ 18 F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ERþ Breast Cancer Undergoing Treatment with Rintodestrant ', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 29, no. 11, pp. 2075-2084 . https://doi.org/10.1158/1078-0432.CCR-22-2720
Purpose: PET with 16α-[18F]-fluoro-17β-estradiol ([18F]FES) allows assessment of whole body estrogen receptor (ER) expression. The aim of this study was to investigate [18F]-fluorodeoxyglucose ([18F]FDG) and [18F]FES PET/CT imaging for response pre
Publikováno v:
International Journal of Clinical and Experimental Physiology. 8:82-87
Background and Aim: Polycystic ovary syndrome (PCOS) and thyroid disorders are commonest endocrine disorders; both of these disorders have profound effect on reproductive function in women’s. An increase in ovarian volume and cystic changes in ovar
Publikováno v:
Qualitative Theory of Dynamical Systems. 21
Autor:
Carolien P. Schröder, Mark D. Pegram, Ramsha Iqbal, Jorianne Boers, Agnes Jager, Marina Maglakelidze, Linnea Chap, Catharina W Menke-van der Houven van Oordt, Susanna Varkey Ulahannan, E. Claire Dees, Adrian Crijanovschi, Wenli Tao, Christina Sipes, Iurie Bulat, Curt Douglas Wolfgang, Philippe Aftimos, Rajesh K. Malik, Patrick Neven, Massimo Cristofanilli, Erika Hamilton, Sarika Jain
Publikováno v:
Cancer Research. 81:PS12-04
Background: Rintodestrant (G1T48) is a potent oral selective estrogen receptor degrader (SERD) that competitively binds to the estrogen receptor (ER) and blocks ER signaling in tumors resistant to other endocrine therapies. Preliminary results from P
Publikováno v:
Iqbal, R, Menke-van der Houven van Oordt, C W, Oprea-Lager, D E & Booij, J 2021, ' [ 18 F]FES uptake in the pituitary gland and white matter of the brain ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 9, pp. 3009-3010 . https://doi.org/10.1007/s00259-021-05281-8
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 48(9), 3009-3010. Springer Verlag
European journal of nuclear medicine and molecular imaging, 48(9), 3009-3010. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 48(9), 3009-3010. Springer Verlag
European journal of nuclear medicine and molecular imaging, 48(9), 3009-3010. Springer Verlag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71eb73e302d6f45c993d59edaeed70d1
https://research.vumc.nl/en/publications/f4c65fc3-5823-42be-88a0-a9f9fa66a8f3
https://research.vumc.nl/en/publications/f4c65fc3-5823-42be-88a0-a9f9fa66a8f3
Autor:
Catharina W Menke-van der Houven van Oordt, Tim van de Brug, Tuba Aras, Lemonitsa H. Mammatas, Wouter V. Vogel, Ronald Boellaard, Ramsha Iqbal, Daniela E. Oprea-Lager, Otto S. Hoekstra, Henk M.W. Verheul
Publikováno v:
Diagnostics; Volume 11; Issue 11; Pages: 1954
Diagnostics, 11
Diagnostics
Diagnostics, Vol 11, Iss 1954, p 1954 (2021)
Iqbal, R, Mammatas, L H, Aras, T, Vogel, W V, van de Brug, T, Oprea-Lager, D E, Verheul, H M W, Hoekstra, O S, Boellaard, R & Menke-van der Houven van Oordt, C W 2021, ' Diagnostic performance of [18 f]fdg pet in staging grade 1–2, estrogen receptor positive breast cancer ', Diagnostics (Basel, Switzerland), vol. 11, no. 11, 1954 . https://doi.org/10.3390/diagnostics11111954
Diagnostics, 11, 11
Diagnostics (Basel, Switzerland), 11(11):1954. MDPI AG
Diagnostics, 11
Diagnostics
Diagnostics, Vol 11, Iss 1954, p 1954 (2021)
Iqbal, R, Mammatas, L H, Aras, T, Vogel, W V, van de Brug, T, Oprea-Lager, D E, Verheul, H M W, Hoekstra, O S, Boellaard, R & Menke-van der Houven van Oordt, C W 2021, ' Diagnostic performance of [18 f]fdg pet in staging grade 1–2, estrogen receptor positive breast cancer ', Diagnostics (Basel, Switzerland), vol. 11, no. 11, 1954 . https://doi.org/10.3390/diagnostics11111954
Diagnostics, 11, 11
Diagnostics (Basel, Switzerland), 11(11):1954. MDPI AG
BackgroundAccurate staging of early breast cancer (BC) patients is essential for tailored treatment. Currently, the preferred imaging modality for staging is positron emission tomography with [18F]Fluorodeoxyglucose (FDG PET) combined with a diagnost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0be8552479f28a5c5627b3ec6164528a
https://doi.org/10.21203/rs.3.rs-695998/v1
https://doi.org/10.21203/rs.3.rs-695998/v1